Keywords: کلدریبیون; Progressive multiple sclerosis; Neurofilaments; Cerebro-spinal fluid; Cladribine; Disease activity;
مقالات ISI کلدریبیون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کلدریبیون; Quantum chemical calculations; Drug delivery; Pristine and functionalized carbon nanotubes; Cladribine; Functionalization mechanisms;
Keywords: کلدریبیون; Cladribine; HCL treatment; Rituximab; Treatment efficacy; Vemurafenib;
Keywords: کلدریبیون; Cladribine; Cytarabine; Idarubicin; Acute myeloid leukemia; Induction chemotherapy; Leukemia risk; NCCN; ELN; Anthracycline; Risk prediction; Prognosis; AML;
Keywords: کلدریبیون; Cladribine; Hairy cell leukemia; Long term outcomes; Purine analog; Survival;
Keywords: کلدریبیون; NPYUAFWUHPXCMD-LRCODCRCSA-N; Anti-leukemia activity; Adenosine; Boron clusters; Cladribine; Fludarabine; Apoptotic potential;
Keywords: کلدریبیون; Cladribine; Fludarabine; Prodrugs; 1,2-, 1,3-Diacylglycerophospholipids; Antiproliferative activity; Pharmacokinetic properties;
Keywords: کلدریبیون; Hairy cell leukaemia; Purine analogue; Pentostatin; Cladribine; Rituximab; Chemoimmunotherapy; Survival;
Keywords: کلدریبیون; AML; ALL; Cladribine; 2-CdA; Clofarabine; Fludarabine; Forodesine; Nelarabine; Purine nucleoside analogs;
Keywords: کلدریبیون; Celiac Disease; Cladribine; Enteropathy-Associated T-Cell Lymphoma; Hematopoietic Stem Cell TransplantationCladribina; Doença Celíaca; Transplante de Células Estaminais Hematopoiéticas; Linfoma de Células T Associado a Enteropatia
A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML
Keywords: کلدریبیون; AML; Cladribine; Clofarabine; GCSF; Relapsed/refractory;
Langerhans cell histiocytosis in children
Keywords: کلدریبیون; BRAF; cladribine; clofarabine; cytarabine; diabetes insipidus; Langerhans cell histiocytosis; steroids; vinblastine;
Progressive multifocal leukoencephalopathy in a patient with systemic mastocytosis treated with cladribine
Keywords: کلدریبیون; Progressive multifocal leukoencephalopathy; JC polyomavirus; Mastocytosis; Cladribine; CD4T lymphocytes; Immunosuppression; Multiple sclerosis;
Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells
Keywords: کلدریبیون; LC-MS/MS; Nucleoside 5â²-triphosphate; Cladribine; Fludarabine; Clofarabine; 2â²-Deoxyadenosine 5â² -triphosphate;
How can one optimize induction therapy in AML?
Keywords: کلدریبیون; Acute myeloid leukemia; AML; Ara-C; Azacitidine; Induction; Cladribine; Clofarabine; CPX-351; Cytarabine; Daunorubicin; Etoposide; Fludarabine; Gemtuzumab ozogamicin; Idarubicin; Vadastuximab talirine;
Erdheim Chester Disease treated successfully with cladribine
Keywords: کلدریبیون; Erdheim Chester Disease; Langerhans cell histiocytosis; Cladribine; Treatment
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis
Keywords: کلدریبیون; Dendritic cells; T cell; B cell; Multiple sclerosis; Cladribine; Immunosuppresant;
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis
Keywords: کلدریبیون; EAE; EPSC; IL-1β; Microglia; Striatum; Cladribine;
Nuevos tratamientos para la esclerosis múltiple
Keywords: کلدریبیون; Esclerosis múltiple; Alemtuzumab; Cladribina; Daclizumab; Dalfampridina; Dimetil fumarato; Fingolimod; Laquinimod; Rituximab; TeriflunomidaMultiple sclerosis; Alemtuzumab; Cladribine; Daclizumab; Dalfampridine; Dimethyl fumarate; Fingolimod; Laquinimod; R
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview
Keywords: کلدریبیون; Multiple sclerosis; T- and B-lymphocytes; Fingolimod; Laquinimod; Cladribine; TeriflunomideMS, multiple sclerosis; CNS, central nervous system; RRMS, relapsing remitting MS; PPMS, primary progressive MS; SPMS, secondary progressive MS; PRMS, progressive r
Cladribine as a therapeutic option in multiple sclerosis
Keywords: کلدریبیون; Cladribine;; Multiple sclerosis;; Immunosuppressant;; Oral drugs
Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study
Keywords: کلدریبیون; chronic lymphocytic leukemia; microarrays; gene expression profiling; fludarabine; cladribine
Flipping the cyclin D1 switch in mantle cell lymphoma
Keywords: کلدریبیون; epigenetics; mantle cell lymphoma; MCL; cladribine; vorinostat; rituximab; cyclin D1; IgH; methylation; histone; CTCF; t(11;14); CD20; bortezomib; curcumin; PD0332991; nucleophosmin
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity
Keywords: کلدریبیون; Cladribine; Deoxycytidine kinase; Immunomodulation; Multiple sclerosis; Purine nucleoside; T cells;
Emerging disease-modifying oral therapies for multiple sclerosis
Keywords: کلدریبیون; Multiple sclerosis (MS); Fingolimod (FTY720); Cladribine; Laquinimod (LAQ); Dimethylfumarate (BG00012); Teriflunomide
Promising Emerging Therapies for Multiple Sclerosis
Keywords: کلدریبیون; Alemtuzumab; Daclizumab; BG-12; Fumarate; Cladribine; Fingolimod; Laquinimod; Teriflunomide;
Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG)
Keywords: کلدریبیون; Acute myeloid leukemia; Infections; Chemotherapy; Cladribine; Neutropenia
Spumous histiocytic oligoarthritis coexisting with systemic Langerhans’ cell histiocytosis: Case report and literature review
Keywords: کلدریبیون; Langerhans’ cell histiocytosis; Synovitis; Erdheim–Chester disease; Arthritis; Cladribine
Oligoarthrite à histiocytes spumeux associée à une histiocytose systémique langerhansienne : observation et revue de la littérature
Keywords: کلدریبیون; Histiocytose langerhansienne; Synovite; Maladie d’Erdheim-Chester; Arthrite; Cladribine
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML
Keywords: کلدریبیون; Relapsed leukemia; Refractory leukemia; Acute myeloid leukemia; Imatinib mesylate; Cladribine; Cytarabine; Filgrastim
Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues
Keywords: کلدریبیون; RNA processing; Transcription; Polyadenylation inhibition; Nucleoside analogs; Cladribine; Clofarabine; Fludarabine
Characterisation of an inclusion complex between cladribine and 2-hydroxypropyl-β-cyclodextrin*
Keywords: کلدریبیون; cladribine; cyclodextrins; inclusion compounds; FT-IR; NMR spectroscopy; thermal analysis; oral drug delivery;
Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment
Keywords: کلدریبیون; Hairy cell leukaemia; Paraproteinemic demyelinating neuropathy; IgM paraprotein; Myelin associated glycoprotein; Cladribine
Comparison of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma
Keywords: کلدریبیون; Ultra performance liquid chromatography; Atmospheric pressure chemical ionization; Photoionization; Cladribine; Clofarabine
Immunosuppressive Agents in Multiple Sclerosis
Keywords: کلدریبیون; Multiple sclerosis; immunosuppressive agents; mitoxantrone; azathioprine; cyclophosphamide; methotrexate; mycophenolate mofetil; cladribine; (tem)sirolimus;
Presence of the anti-leukemic nucleotide analog, 2-chloro-2â²-deoxyadenosine-5â²-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP)
Keywords: کلدریبیون; Hairy cell leukemia; Transcription factors; RNA polymerase II; TATA-binding protein; Protein:protein associations; Promoter sequence; Protein conformation; Cladribine; Cancer drug; DNA minor groove;
Recent progress in the management of chronic lymphocytic leukemia
Keywords: کلدریبیون; Chronic lymphocytic leukemia; Purine nucleoside analogs; Fludarabine; Cladribine; Pentostatin; Rituximab; Alemtuzumab; Chemoimmunotherapy; Monoclonal antibodies; Stem cell transplantation
Current treatment options in hairy cell leukemia and hairy cell leukemia variant
Keywords: کلدریبیون; Hairy cell leukemia; Variant form; Purine nucleoside analogs; Cladribine; Pentostatin; Interferon α; Rituximab; BL22; Immunotoxins; Splenectomy
Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: A systematic review and meta-analysis
Keywords: کلدریبیون; Chronic lymphocytic leukemia; CLL; Purine analogs; Fludarabine; Cladribine; Meta-analysis; Systematic review
Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies
Keywords: کلدریبیون; Fludarabine; Cladribine; Alemtuzumab; Rituximab; CLL; Treatment;